Benitec Biopharma Inc. (BNTC)
10.87
0.11 (1.02%)
At close: Jan 29, 2025, 3:59 PM
10.87
0.00%
After-hours Jan 29, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -21.75M | -19.56M | -18.21M | -13.88M | -8.27M | 2.61M | -8.55M | -4.37M | -18.50M | -8.83M | -10.84M | -6.42M |
| Depreciation & Amortization | 343.00K | 381.00K | 392.00K | 424.00K | 374.00K | 158.00K | n/a | 217.00K | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 830.00K | 452.00K | 870.00K | 634.00K | 237.00K | 957.20K | n/a | 386.00K | n/a | n/a | n/a | n/a |
| Other Working Capital | 233.00K | 714.00K | 1.04M | 8.00K | 126.00K | -24.00K | n/a | 760.00K | n/a | n/a | n/a | n/a |
| Other Non-Cash Items | 1K | 717.00K | 10.00K | -16.00K | 2.00K | 700.00K | n/a | -4.47M | -1.70M | -864.59K | 1.14M | -2.85M |
| Deferred Income Tax | n/a | -714.00K | n/a | n/a | n/a | -957.20K | n/a | -819.52K | n/a | n/a | n/a | n/a |
| Change in Working Capital | 1.17M | 714.00K | 1.04M | 8.00K | 126.00K | 1.32M | n/a | 760.00K | n/a | n/a | n/a | n/a |
| Operating Cash Flow | -19.40M | -18.01M | -15.90M | -12.83M | -7.54M | 4.79M | -8.55M | -8.30M | -20.21M | -9.69M | -9.69M | -9.27M |
| Capital Expenditures | -179.00K | -1K | -13.00K | -221.00K | -95.00K | -403.40K | -60.97K | -131.41K | -255.40K | -387.34K | -475.46K | -29.20K |
| Acquisitions | n/a | n/a | n/a | n/a | 1K | 4.00K | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -131.00K | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | -0.00 | 202.03 | -47.01K | 30.33K | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -179.00K | -1K | -13.00K | -221.00K | -94.00K | -399.19K | -107.99K | -232.07K | -255.40K | -387.34K | -475.46K | -29.20K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -5.89M | -1.87M | n/a | -3.23M | -480.00K | -688.11K | -229.93K | 1.74M | 2.98M | -255.41K | -313.52K | n/a |
| Financial Cash Flow | 68.03M | 16.02M | n/a | 22.52M | 1.77M | -688.11K | 6.25M | 6.10M | 17.51M | 39.88K | 48.96K | 35.66M |
| Net Cash Flow | 48.44M | -1.59M | -15.71M | 9.97M | -5.92M | 4.43M | -947.62K | -657.02K | -2.66M | -7.34M | -9.01M | 27.17M |
| Free Cash Flow | -19.58M | -18.01M | -15.91M | -13.05M | -7.63M | 4.39M | -8.61M | -8.44M | -20.46M | -10.08M | -10.17M | -9.30M |